Navigation Links
Roxane Laboratories, Inc. Announces the Launch of Granisetron Hydrochloride Tablets, 1mg
Date:1/3/2008

COLUMBUS, Ohio, Jan. 2 /PRNewswire/ -- Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application (ANDA) for Granisetron Hydrochloride Tablets, 1mg by the U.S. Food and Drug Administration. The product is available in Unit Dose Blisters and is available for immediate shipment to wholesalers and pharmacies nationwide.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070410/CLTU122LOGO )

Roxane Laboratories' Granisetron Hydrochloride Tablets are AB rated to KYTRIL(R) (granisetron hydrochloride) Tablets. Annual sales of Granisetron Hydrochloride Tablets, 1mg are approximately $89 Million(1).

Full prescribing information for Granisetron Hydrochloride Tablets is available on the Roxane Laboratories website at http://www.Roxane.com or upon request by calling Roxane Laboratories Technical Product Information at 1.800.962.8364.

About Roxane Laboratories, Inc.

Roxane Laboratories is located in Columbus, OH in a modern 500,000 square foot manufacturing and laboratory facility. The facility spans 70 acres and currently employs over 1,000 people. Currently, Roxane Laboratories markets over 75 medications in nearly 250 package sizes, focusing on an expanding line of Multisource pharmaceutical products including: bulk and unit-dose liquids and solids; coated, sustained-release and controlled-release tablets; nasal sprays, cytotoxics and CII narcotics.

Roxane Laboratories, Inc., is a subsidiary of Boehringer Ingelheim Corporation, based in Ridgefield, CT and a member of the Boehringer Ingelheim group of companies.

About Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 137 affiliates in 47 countries and approximately 38,400 employees
'/>"/>

SOURCE Roxane Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Roxane Laboratories, Inc. Announces the Launch of Balsalazide Disodium Capsules, 750mg
2. Roxane Laboratories, Inc. Announces the Launch of Oxcarbazepine Tablets, 150mg, 300mg and 600mg
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Zyrtec Allergy Tablets(R) and Zyrtec Hives Relief Tablets(R)
4. Bond Laboratories, Inc. Announces 2-for-1 Forward Split
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Norvasc(R)
6. Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lexapro(R)
7. Getting Ready Corporation and Winston Laboratories, Inc. Announce Merger Agreement
8. Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lamictal(R)
9. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Second Quarter Earnings
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Francisco, CA (PRWEB) May 22, 2015 ... hosting two exciting events in June. They will hold ... Professional Doctorate and a two-day class on Classical Chinese ... p.m. June 3, Dr. Steve Given, the Dean of ... will discuss the new First Professional Doctorate program. ACTCM ...
(Date:5/22/2015)... York, New York (PRWEB) May 22, 2015 ... http://www.xareltolawsuit2015.com/ ) filed on behalf of individuals who ... due to its use continue to move forward ... Louisiana. According to a Pretrial Order dated May ... the preservation of documents and electronically stored information. ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Combination ... treatment option for chronic obstructive pulmonary disorder (COPD) ... plc and AstraZeneca plc as well as Germany’s ... share and position. But will market payers, clinicians ... already well-entrenched products to completely new ones? , ...
(Date:5/22/2015)... Family, friends, students, colleagues, mentors and ... Dr. LaSalle D. Leffall, on Monday, May 18, with ... Grand Rounds in the hospital’s Tower Auditorium. Leffall’s younger ... auditorium, trying to keep the secret. “I’d like to ... me, he’ll know something is up,” she said. , ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Memorial Day weekend ... Amica Insurance is offering some tips to help promote ... Council, there will be 383 traffic fatalities this Memorial Day ... the National Highway Traffic Safety Association: , ... the vehicle is wearing a seatbelt, whether they’re driving or ...
Breaking Medicine News(10 mins):Health News:ACTCM Announces Upcoming June Events 2Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 2Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 3Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 4Health News:Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com 2Health News:Colleagues Surprise Dr. LaSalle Leffall with 85th Birthday Celebration 2Health News:Amica Has 4 Road Safety Tips for Memorial Day Weekend 2
... With infections typically causing only mild illness, experts point to ... (HealthDay News) -- With all the warnings and preparations, dire ... H1N1 swine flu prove more disruptive than the actual outbreak? ... than a few infectious-disease experts as the fall and winter ...
... SEATTLE, Sept. 22 Milliman, Inc., one of the premier worldwide ... new office in San Juan, Puerto Rico. The consultancy, in concert ... expanding the range and depth of Milliman health-related service offerings. , ... years of experience are ideally suited to meeting client needs in ...
... , RADNOR, Pa., Sept. 22 Eric Hipple, ... Feeling Blue Suicide Prevention Council,s Swing into Life! Golf Tournament, Wednesday, ... former National Football League (NFL) quarterback whose ten year career was ... a divisional championship, and the most valuable NFL player award for ...
... , , , ... Bulletin Board: AEMD) today announced that it has initiated ... to support large-scale production of the active affinity agents ... allow the Hemopurifer(R) to selectively capture a broad-spectrum of ...
... PITTSBURGH, Sept. 22 Cohera Medical, Inc. announced ... 13485:2003 International Standard for the Design, Development, and Manufacture ... Cohera Medical to proceed with the CE Mark registration ... surgical adhesive, upon completion of development for its first ...
... PITTSBURGH, Sept. 22 Precision Therapeutics today announced that its ... Business Magazine 2009 Pacesetters Award. This award recognizes business ... setting the pace for the region. The award honors ... in the community-at-large as well as within their own organizations, ...
Cached Medicine News:Health News:Could Swine Flu Panic Be Worse Than Outbreak Itself? 2Health News:Could Swine Flu Panic Be Worse Than Outbreak Itself? 3Health News:Could Swine Flu Panic Be Worse Than Outbreak Itself? 4Health News:Milliman Announces the Opening of a New Office in San Juan, Puerto Rico 2Health News:Former NFL Quarterback to Speak at Local Nonprofit Fundraising Event 2Health News:Aethlon Medical Initiates Relationship to Establish Large Scale Production of Hemopurifier(R) Affinity Agents 2Health News:Aethlon Medical Initiates Relationship to Establish Large Scale Production of Hemopurifier(R) Affinity Agents 3Health News:Cohera Medical Receives ISO 13485 Certification: Company Meets International Standards for Design, Development and Manufacturing of Medical Devices 2Health News:Precision Therapeutics President and CEO Sean McDonald Recipient of 2009 Pacesetters Award 2
(Date:5/22/2015)... TORONTO , May 22 2015 /CNW/ - The Taskforce ... are very appreciative of all the hard work that the ... the past six months. This program recognizes the needs of ... receive at least $75,000 a year, tax free, with annual ... will be eligible for annual payments of $100,000 based on ...
(Date:5/22/2015)... mayo de 2015 Dipexium Pharmaceuticals, ... farmacéutica de fase tardía centrada en el ... 0.8%), y colaboradores de investigación clínica, han ... el diseño innovador de los ensayos pivotales ... evalúan Locilex®, su nuevo péptido de antibiótico ...
(Date:5/22/2015)... 2015  Effective staffing of key marketing services ... success. Research and consulting leader ... pharmaceutical and biotech marketing managers with metrics detailing ... are being channeled into marketing operations of global ... utilize this report to benchmark their own resource ...
Breaking Medicine Technology:Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 2Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 3Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 4Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 5Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 6Effective Marketing Services Group Critical for Pharmaceutical Brand Recognition 2
... Sciences International, Inc. (Nasdaq: BDSI ) announced ... Officer of BDSI, will present at the Jeffries Global ...  The presentation is scheduled for Thursday, June 9 at ... http://photos.prnewswire.com/prnh/20110217/CL49801LOGO ) Dr. Sirgo will focus on ...
... bioTheranostics, Inc., a bioMerieux company that develops innovative ... today findings from clinical studies utilizing the company,s ... the studies were presented this week at the ... Meeting in Chicago. On June 6, ...
Cached Medicine Technology:BioDelivery Sciences to Present at the Jeffries Global Healthcare Conference 2BioDelivery Sciences to Present at the Jeffries Global Healthcare Conference 3Data from Clinical Studies of bioTheranostics' CancerTYPE ID® and Breast Cancer Index(SM) Molecular Diagnostic Tests Presented at ASCO 2011 Annual Meeting 2Data from Clinical Studies of bioTheranostics' CancerTYPE ID® and Breast Cancer Index(SM) Molecular Diagnostic Tests Presented at ASCO 2011 Annual Meeting 3
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Medicine Products: